selected scholarly activity
-
chapters
- Artificial intelligence in neurologic disease. 253-264. 2024
- Molecular and Functional Imaging in Oncology Therapy Response. Medical Radiology. 255-272. 2020
- Cardiac Imaging. 115-144. 2019
- SPECT and SPECT/CT for the Skeletal System. 127-146. 2017
- SPECT and SPECT/CT in Neoplastic Disease. 114-126. 2017
- Selected Interesting SPECT and SPECT/CT Cases. 181-197. 2017
- Case 100. 213-214. 2015
- Case 101. 215-216. 2015
- Case 102. 217-218. 2015
- Case 103. 219-220. 2015
- Case 104. 221-222. 2015
- Case 105. 223-224. 2015
- Case 106. 225-226. 2015
- Case 107. 227-228. 2015
- Case 108. 229-230. 2015
- Case 109. 231-232. 2015
- Case 110. 233-234. 2015
- Case 111. 235-236. 2015
- Case 112. 237-238. 2015
- Case 113. 241-242. 2015
- Case 114. 243-244. 2015
- Case 115. 245-246. 2015
- Case 116. 247-248. 2015
- Case 117. 249-250. 2015
- Case 118. 251-252. 2015
- Case 119. 253-254. 2015
- Case 120. 255-256. 2015
- Case 121. 257-258. 2015
- Case 122. 259-260. 2015
- Case 123. 261-262. 2015
- Case 124. 263-264. 2015
- Case 125. 265-266. 2015
- Case 126. 267-268. 2015
- Case 127. 269-270. 2015
- Case 128. 271-272. 2015
- Case 129. 273-274. 2015
- Case 130. 275-276. 2015
- Case 131. 279-280. 2015
- Case 132. 281-282. 2015
- Case 133. 283-284. 2015
- Case 134. 285-286. 2015
- Case 135. 287-288. 2015
- Case 136. 289-290. 2015
- Case 153. 327-328. 2015
- Case 154. 329-330. 2015
- Case 155. 331-332. 2015
- Case 156. 333-334. 2015
- Case 157. 335-336. 2015
- Case 158. 337-338. 2015
- Case 159. 339-340. 2015
- Case 160. 341-342. 2015
- Case 161. 343-344. 2015
- Case 91. 195-196. 2015
- Case 92. 197-198. 2015
- Case 93. 199-200. 2015
- Case 94. 201-202. 2015
- Case 95. 203-204. 2015
- Case 96. 205-206. 2015
- Case 97. 207-208. 2015
- Case 98. 209-210. 2015
- Case 99. 211-212. 2015
- Bladder carcinoma. 191-199. 2014
- Renal carcinoma. 179-190. 2014
- Sports Injuries. 385-396. 2014
- Cancers of the Esophagus and Small Bowel, Precancerous States of the Large Bowel, and Gastrointestinal Stromal Tumors. 423-450. 2013
- Radionuclide Therapy of Bone Metastases. 85-100. 2013
- Sarcoma. 466-486. 2012
-
conferences
- Is segmentation performance of deep-learning models affected by cancer type? A performance analysis on PET/CT. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 130-130. 2025
- Hardware-Compatible U-Net for Low-Dose PET Reconstruction. Proceedings of The International Symposium on Multiple-Valued Logic. 51-56. 2025
- Calibration Procedures for Multi-Center Dosimetry Studies with 177Lu Radiopharmaceuticals: Experience from the Canadian Cancer Trial Group PR.21 Trial (NCT 04663997). Journal of Nuclear Medicine. 2024
- Diagnostic accuracy of SPECT for mild traumatic brain injury: a systematic review and meta-analysis. Journal of Nuclear Medicine. 2024
- First outcomes from OZM-067-a multicenter single arm study of 177Lu-DOTATATE therapy for primary site agnostic 68Ga-DOTATATE PET positive progressive metastatic neuroendocrine tumors. Journal of Nuclear Medicine. 2024
- Random Forest and K-Means Clustering Algorithms to Classify of 18F-Florbetapir Brain PET. Proceedings of The International Symposium on Multiple-Valued Logic. 167-171. 2024
- Inter- and intra-reader reproducibility of 18F-rhPSMA-7.3 PET interpretation in patients with newly diagnosed prostate cancer: Results from a phase 3, prospective, multicenter study (LIGHTHOUSE). Journal of Nuclear Medicine. 2023
- Calibration Procedures for Multi-Center Dosimetry Studies with Lu-177 Radiopharmaceuticals: Early Experience from the Canadian Cancer Trial Group PR.21 Trial (NCT 04663997). European Journal of Nuclear Medicine and Molecular Imaging. S186-S187. 2022
- CCTG PR21: A randomized phase II study of [177lu]lu-PSMA-617 verus docetaxel in patients with metastatic castration-resistant prostate cancer and PSMA-positive disease (NCT04663997). Journal of Clinical Oncology. 2022
- CCTG PR21: A randomized phase II study of [177lu]lu-PSMA-617 verus docetaxel in patients with metastatic castration-resistant prostate cancer and PSMA-positive disease (NCT04663997).. Journal of Clinical Oncology. TPS5110-TPS5110. 2022
- Effect of 18F-DCFPyL PET/CT (=PSMA PET) on the management of patients with suspected limited residual/recurrent disease following radical prostatectomy: Results of a prospective, multicenter registry trial. European Urology. S299-S299. 2022
- Amyloid-PETand free-water diffusion MRI of the white matter: a multi-center mixed cohort of small vessel disease and Alzheimer's disease pathology. Journal of Cerebral Blood Flow and Metabolism. 193-194. 2021
- PSMA-PET/CT Registry for Recurrent Prostate Cancer (PREP): Initial findings from a single center.. Journal of Clinical Oncology. 5064-5064. 2021
- A Prospective Provincial PSMA-PET Registry for Recurrent Prostate Cancer: Preliminary results. International Journal of Radiation Oncology Biology Physics. e877-e878. 2020
- Bone scan use in the management of metastatic castration-resistant prostate cancer: Survey of practice patterns among Canadian radiation oncologists, medical oncologists, and urologists. Journal of the Canadian Urological Association. E601-E603. 2020
- Optimizing the SPECT Imaging Workflow For Individualized Dosimetry in Lu177-DOTATATE Treatment Of Progressive Metastatic Neoendocrine Tumors. International Journal of Radiation Oncology Biology Physics. e588-e589. 2020
- A PROSPECTIVE PROVINCIAL PSMA-PET REGISTRY FOR RECURRENT PROSTATE CANCER: PRELIMINARY RESULTS. Radiotherapy and Oncology. S30-S30. 2020
- Deep learning-based detection of bone lesions in Tc-99m-MDP SPECT: comparison with human observers. Journal of Nuclear Medicine. 2020
- Preliminary results of a prospective, multicenter trial assessing the impact of F-18-DCFPyL-PET/CT on the management of patients with recurrent prostate cancer.. Journal of Nuclear Medicine. 2020
- FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2020
- FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 23-23. 2020
- 70 Quantifying Tumour Dose Using Individualized Dosimetry Methodology in 177LU Dotatate Therapy. Radiotherapy and Oncology. S32-S32. 2019
- DRIVE: DEFINING RADIORECURRENT INTRAPROSTATIC TARGET VOLUMES. Radiotherapy and Oncology. S4-S4. 2019
- QUANTIFYING TUMOUR DOSE USING INDIVIDUALIZED DOSIMETRY METHODOLOGY IN 177LU DOTATATE THERAPY. Radiotherapy and Oncology. S32-S32. 2019
- Use of Iterative Reconstruction for Dose Optimisation of Paediatric Tc-99m MDP Bone SPECT. European Journal of Nuclear Medicine and Molecular Imaging. S326-S327. 2019
- DRIVE: Defining Radiorecurrent Intraprostatic Target Volumes. International Journal of Radiation Oncology Biology Physics. E291-E291. 2019
- Quantifying Renal And Tumor Doses with Individualized Dosimetry In 177Lu DOTATATE Therapy – What Difference Does It Make?. International Journal of Radiation Oncology Biology Physics. S205-S205. 2019
- A phase I study of [225Ac]-FPI-1434 radioimmunotherapy in patients with IGF-1R expressing solid tumors.. Journal of Clinical Oncology. TPS3152-TPS3152. 2019
- Individualized dosimetry for Lu177 DOTATATE therapy - What difference does it make?. Journal of Nuclear Medicine. 2019
- Non-Binary Approaches for Classification of Amyloid Brain PET. Proceedings of The International Symposium on Multiple-Valued Logic. 206-211. 2019
- Advanced Prostate Imaging of Recurrent Cancer after Radiation Therapy (PICs): Interim Results of a Prospective, Multi-Center Trial. International Journal of Radiation Oncology Biology Physics. e126-e126. 2018
- F-18-DCFPyL PET/CT in Castration-Resistant Prostate Cancer (CRPC): Imaging results prior to and following abiraterone or enzalutemide therapy. Journal of Nuclear Medicine. 2018
- PSMA imaging with F-18-DCFPyL: evaluation of different normalization methods for uptake measurement. Journal of Nuclear Medicine. 2018
- Stereotactic ablative radiotherapy (SABR) for oligoprogressive metastatic castration-resistant prostate cancer (mCRPC) during abiraterone therapy: A phase I study. Annals of Oncology. 2017
- An Approach to New Oncologic PET Agent Development. Journal of Nuclear Medicine. 2017
- Improved epileptic foci localization using joint SPECT reconstruction: Phantom and patient studies. Journal of Nuclear Medicine. 2016
- Phase 1 study with expansion cohorts of cabozantinib (C) + abiraterone (A) in metastatic castration resistant prostate cancer (mCRPC): Investigator-sponsored study.. Journal of Clinical Oncology. 5037-5037. 2015
- Evaluation of refractory epilepsy in children using 3D-SSP (NEUROSTAT) and FDG-PET. Journal of Nuclear Medicine. 2014
- PET and MRI associations across a spectrum of pediatric brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC). Journal of Nuclear Medicine. 2014
- Prognostic value of baseline evaluation of FDG and NaF PET/CT in castrate-resistant prostate cancer (CRPC): Early results from a prospective phase 1 trial. Journal of Nuclear Medicine. 2014
- A practical approach to PET/MRI: Common abdominal pathology in oncology. Journal of Nuclear Medicine. 2013
- Abstract LB-166: Cabozantinib (cabo) + abiraterone (abi) combination therapy in castration resistant prostate cancer (CRPC): preclinical evaluation and interim results of an investigator-sponsored phase 1 clinical study.. Cancer Research. 2013
- Beyond Dose Guidelines: Lower Minimum Radiopharmaceutical Administered Doses in Pediatric Hepatobiliary Scintigraphy: Application of Enhanced Planar Processing.. European Journal of Nuclear Medicine and Molecular Imaging. S237-S237. 2012
- Dose reduction in newborns and infants undergoing hepatobiliary scintigraphy. Journal of Nuclear Medicine. 2012
- Registration of MR permeability and FDG uptake in pediatric brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC). Journal of Nuclear Medicine. 2012
- Role of CT, MRI, and PET/CT in Management of Myeloid Sarcoma With Clinical and Pathologic Correlation. American Journal of Roentgenology. 2012
- In pediatric Hodgkin's disease, diffuse marrow uptake on staging FDG-PET correlates with B symptoms. Journal of Nuclear Medicine. 2011
- Metabolic response by FDG-PET correlates with exon11 KIT mutation in patients with mucosal or acral melanoma or melanoma arising on chronically sun damaged skin treated with imatinib in a phase II trial. Journal of Nuclear Medicine. 2011
- END OF TREATMENT BUT NOT INTERIM PET SCAN PREDICTS OUTCOME IN NON-BULKY LIMITED STAGE HODGKIN LYMPHOMA. Haematologica. S16-S16. 2010
- Dose reduction in pediatric MAG-3 renal scans. Journal of Nuclear Medicine. 2009
- Pediatric reference ranges for glomerular filtration rate determined by a single injection of Tc-99m DTPA. Journal of Nuclear Medicine. 2009
- The Utility of Bone Scintigraphy in Pediatric Patients (CME Credit Available). American Journal of Roentgenology. 2009
- The role of FDG-PET in the pre-surgical evaluation of children with intractable epilepsy. Journal of Nuclear Medicine. 2009
- The role of bone scintigraphy in the evaluation of children with fever of unknown origin. Journal of Nuclear Medicine. 2009
- Uniformity of FDG uptake in pediatric brain stem gliomas predicts survival. Journal of Nuclear Medicine. 2009
-
journal articles
- Erratum for: Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.. Radiology. 315:e259010. 2025
- MRS demonstrates elevated brain glutathione in vascular mild cognitive impairment compared to cognitively normal coronary artery disease controls.. Alzheimer's and Dementia. 21:e70230. 2025
- 18 F-DCFPyL in the Detection of Prostate Cancer Spread to the Lumbosacral Plexus.. Clinical Nuclear Medicine. 50:e232-e233. 2025
- A prospective provincial registry of PSMA PET CT for recurrent prostate cancer (PREP): Results for 4135 men.. Journal of Clinical Oncology. 43. 2025
- Patterns of failure with 18F-DCFPyL PSMA-PET/CT in the post-prostatectomy setting A regional cohort analysis.. Journal of the Canadian Urological Association. 19:17-24. 2025
- Basic Science and Pathogenesis.. Alzheimer's and Dementia. 20 Suppl 1:e084982. 2024
- Performance and Interpretation of Lung Scintigraphy. Clinical Nuclear Medicine. 49:997-1003. 2024
- Diagnostic Accuracy of SPECT for Mild Traumatic Brain Injury. Clinical Nuclear Medicine. 49:938-947. 2024
- 124 Phase II Randomized Trial of Optimal Recurrence-Directed Therapy (RDT) Without or with Androgen-Deprivation Therapy (ADT) in Radio-Recurrent Oligo-Metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC): The OCOG-Rational-PCS Trial. Radiotherapy and Oncology. 198:s54-s55. 2024
- Interreader and Intrareader Reproducibility of18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. Journal of Nuclear Medicine. 65:1239-1243. 2024
- Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology. Alzheimer's and Dementia. 20:3687-3695. 2024
- Role of PET/Computed Tomography in Gastric and Colorectal Malignancies. PET Clinics. 19:177-186. 2024
- EFFECTS OF VASCULAR BURDEN ON COGNITION ARE MEDIATED BY ATROPHY, AMYLOID, AND GLUCOSE METABOLISM: A MULTI-CENTRE MIXED COHORT OF SMALL VESSEL DISEASE AND ALZHEIMER'S PATHOLOGY. Cerebral Circulation - Cognition and Behavior. 6:100105-100105. 2024
- Wavelet phase coherence of ictal scalp EEG-extracted muscle activity (SMA) as a biomarker for sudden unexpected death in epilepsy (SUDEP).. PLoS ONE. 19:e0298943. 2024
- Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial. Blood. 142:3042-3042. 2023
- ACR Appropriateness Criteria® Left Lower Quadrant Pain: 2023 Update. Journal of the American College of Radiology. 20:S471-S480. 2023
- Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE). European Urology. 84:361-370. 2023
- Diagnostic Performance and Safety of 18 F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Investigative Urology. 210:299-311. 2023
- Understanding the Value of FAPI versus FDG PET/CT in Primary and Metastatic Lung Cancer. Radiology. 308:e231768. 2023
- The Global Reading Room: Performing a Gastric Emptying Study. American Journal of Roentgenology. 221:139-140. 2023
- Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease. Cerebrovascular and Brain Metabolism Reviews. 43:921-936. 2023
- Relationships between polymorphisms in EPHX2, CYP2J2, CYP2C9, and CYP2C8, white matter hyperintensities, and regional atrophy. Alzheimer's and Dementia. 19. 2023
- Rituximab combined with chemotherapy and acalabrutinib prior to autologous stem cell transplantation in mantle cell lymphoma: The Rectangle Trial. Hematological Oncology. 41:483-484. 2023
- ACR Appropriateness Criteria® Right Upper Quadrant Pain: 2022 Update. Journal of the American College of Radiology. 20:S211-S223. 2023
- Re: "Overcoming Challenges Associated with 18F-DCFPyL PET Imaging in Prostate Cancer".. Canadian Journal of Urology. 30:11465-11466. 2023
- Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET. Alzheimer's and Dementia. 19:1503-1517. 2023
- 18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer. Clinical and Translational Radiation Oncology. 39:100583-100583. 2023
- Patterns of failure after radiotherapy (RT) in patients with prostate cancer re-staged with 18F-DCFPyL PSMA-PET: A regional cohort analysis.. Journal of Clinical Oncology. 41:45-45. 2023
- Patterns of failure with 18F-DCFPyL PSMA PET/CT in the post-prostatectomy setting: A regional cohort analysis.. Journal of Clinical Oncology. 41:309-309. 2023
- Image acquisition and interpretation of 18F-DCFPyL (piflufolastat F 18) PET/CT: How we do it.. Canadian Journal of Urology. 30:11432-11437. 2023
- A brief overview of targeted radionuclide therapy trials in 2022. Frontiers in Nuclear Medicine. 3:1169650. 2023
- Brain PET and Cerebrovascular Disease. PET Clinics. 18:115-122. 2023
- Ictal ECG-based assessment of sudden unexpected death in epilepsy. Frontiers in Neurology. 14:1147576. 2023
- Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. The Lancet Oncology. 23:1499-1507. 2022
- PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial. BMC Cancer. 22:251. 2022
- 18F-DCFPyL PET/CT in Men with Prostate Cancer. Radiology. 305:429-430. 2022
- ACR Appropriateness Criteria® Right Lower Quadrant Pain: 2022 Update. Journal of the American College of Radiology. 19:S445-S461. 2022
- Re: Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial. Journal of Urology. 208:736-736. 2022
- Beyond the AJR: Tau PET, Amyloid PET, and MRI as Prognostic Markers in Early Alzheimer Disease. American Journal of Roentgenology. 218:924-924. 2022
- Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial. Radiology. 303:414-422. 2022
- Effect of 18F-DCFPyL PET/CT (=PSMA PET) on the management of patients with suspected limited residual/recurrent disease following radical prostatectomy: Results of a prospective, multicenter registry trial. European Urology. 81:S299-S299. 2022
- Management of Differentiated Thyroid Cancer: The Standard of Care. Journal of Nuclear Medicine. 63:189-195. 2022
- A Peri-Ictal EEG-Based Biomarker for Sudden Unexpected Death in Epilepsy (SUDEP) Derived From Brain Network Analysis. Frontiers in Network Physiology. 2:866540. 2022
- Clinical Applications of Artificial Intelligence in Positron Emission Tomography of Lung Cancer. PET Clinics. 17:77-84. 2022
- Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI. Clinical and Translational Radiation Oncology. 32:41-47. 2022
- Evidence-Based Artificial Intelligence in Medical Imaging. PET Clinics. 17:51-55. 2022
- Amyloid‐independent vascular contributions to cortical atrophy and cognition in a multi‐center mixed cohort with low to severe small vessel disease. Alzheimer's and Dementia. 17. 2021
- Polymorphisms in EPHX2 and CYP2J2 moderate associations between white matter hyperintensities and temporal lobe atrophy. Alzheimer's and Dementia. 17:e055592. 2021
- A Radiology-focused Review of Predictive Uncertainty for AI Interpretability in Computer-assisted Segmentation. Radiology: Artificial Intelligence. 3:e210031. 2021
- Case – Prostate-specific antigen bounce: A pitfall in prostate-specific membrane antigen positron emission tomography/computed tomography interpretation. Journal of the Canadian Urological Association. 15:E620-E621. 2021
- Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide. Journal of Nuclear Medicine. 62:1430-1437. 2021
- Role of Artificial Intelligence in Theranostics. PET Clinics. 16:627-641. 2021
- Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects. Journal of Nuclear Medicine. 62:1323-1329. 2021
- Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia. JACC Asia. 1:187-199. 2021
- Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World. JACC Cardiovascular Imaging. 14:1787-1799. 2021
- Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374–82. European Urology. 80:e77-e78. 2021
- Update on Molecular Imaging and Precision Medicine in Lung Cancer. Radiologic Clinics of North America. 59:693-703. 2021
- Machine learning in nuclear medicine: part 1—introduction. Chinese Journal of Nuclear Medicine and Molecular Imaging. 41:501-506. 2021
- Machine learning in nuclear medicine: part 2—neural networks and clinical aspects. Chinese Journal of Nuclear Medicine and Molecular Imaging. 41:507-512. 2021
- Detecting lumbar lesions in 99mTc‐MDP SPECT by deep learning: Comparison with physicians. Medical Physics. 48:4249-4261. 2021
- Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or Negative. Clinical Nuclear Medicine. 46:616-620. 2021
- Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe. Open Heart. 8:e001681-e001681. 2021
- Overview of the First NRG Oncology–National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 62:1133-1139. 2021
- Case – 18F-DCFPyL-positron emission tomography/computed tomography (PET/CT) time of imaging. Journal of the Canadian Urological Association. 15:E376-E379. 2021
- Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician’s guide. Expert Review of Anticancer Therapy. 21:641-655. 2021
- A PHASE II STUDY OF ACALABRUTINIB IN COMBINATION WITH R‐CHOP CHEMOTHERAPY PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA. Hematological Oncology. 39. 2021
- Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer. Journal of the Canadian Urological Association. 15:162-172. 2021
- Artificial intelligence for molecular neuroimaging. ANNALS OF TRANSLATIONAL MEDICINE. 9:822-822. 2021
- Harmonization of U.S., European Union, and Canadian first-in-human regulatory requirements for radiopharmaceuticals: is this possible?. Chinese Journal of Nuclear Medicine and Molecular Imaging. 41:185-192. 2021
- Reporting guidance for oncologic 18F-FDG PET/CT imaging. Chinese Journal of Nuclear Medicine and Molecular Imaging. 41:124-128. 2021
- Internal Jugular Vein and Cerebral Venous Sinus Infective Thrombophlebitis Detected With 99mTc-HMPAO White Blood Cell Scintigraphy. Clinical Nuclear Medicine. 46:e112-e113. 2021
- International Impact of COVID-19 on the Diagnosis of Heart Disease. Journal of the American College of Cardiology. 77:173-185. 2021
- Machine Learning in Nuclear Medicine: Part 2—Neural Networks and Clinical Aspects. Journal of Nuclear Medicine. 62:22-29. 2021
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 62:6-14. 2021
- Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging. Advances in Radiation Oncology. 6:100553-100553. 2021
- Radiographic and metabolic evolution of prostate cancer lung metastasis detected by prostate-specific membrane antigen and fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. World Journal of Nuclear Medicine. 19:421-424. 2020
- 62: A Prospective Provincial Psma-Pet Registry for Recurrent Prostate Cancer: Preliminary Results. Radiotherapy and Oncology. 150:S30-S30. 2020
- Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI in Biochemically Recurrent Prostate Cancer. Radiology. 296:573-574. 2020
- Prostate Cancer Lymphangitic Pulmonary Carcinomatosis. Clinical Nuclear Medicine. 45:727-729. 2020
- Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimer's and Dementia. 16:1182-1195. 2020
- Erratum to: Liu W, Zukotynski K, Emmett L, Chung HT, Chung P, Wolfson R, Rachinsky I, Kapoor A, Metser U, Loblaw A, Morton G, Sexton T, Lock M, Helou J, Berlin A, Boylan C, Archer S, Pond GR, Bauman G. A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. Int J Radiat Oncol Biol Phys 2020;106:546-555.. International Journal of Radiation Oncology Biology Physics. 107:390-390. 2020
- The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score. Clinical Nuclear Medicine. 45:427-433. 2020
- A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy. Journal of the Canadian Urological Association. 14:130-138. 2020
- A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. International Journal of Radiation Oncology Biology Physics. 106:546-555. 2020
- Clinical and Technical Considerations for Brain PET Imaging for Dementia. Journal of Nuclear Medicine Technology. 48:5-8. 2020
- CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment. Alzheimer's and Dementia: Translational Research and Clinical Interventions. 6:e12098. 2020
- Safety of the Use of Radioactive Iodine in Patients With Hyperthyroidism. JAMA Internal Medicine. 179:1738-1738. 2019
- 189 Bone Scans in the Management of Metastatic Castrate-Resistant Prostate Cancer: Survey of Patterns of Practice in Canadian Radiation Oncologists, Medical Oncologists and Urologists. Radiotherapy and Oncology. 139:S79-S80. 2019
- 2 Drive: Defining Radiorecurrent Intraprostatic Target Volumes. Radiotherapy and Oncology. 139:S4-S4. 2019
- The Use of Random Forests to Classify Amyloid Brain PET. Clinical Nuclear Medicine. 44:784-788. 2019
- Fifth Anniversary of SNMMI Professional Relations Fellowship.. Journal of Nuclear Medicine. 60:20N. 2019
- Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network. Journal of Nuclear Medicine. 60:677-682. 2019
- An International Survey of PET/CT Clinical Reporting. Journal of Nuclear Medicine. 60:478-479. 2019
- Machine Learning in Nuclear Medicine: Part 1—Introduction. Journal of Nuclear Medicine. 60:451-458. 2019
- Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?. Journal of Nuclear Medicine. 60:158-166. 2019
- 18F-DCFPyL PET/CT in Oncocytoma. Clinical Nuclear Medicine. 43:921-924. 2018
- Update 2018. Clinical Nuclear Medicine. 43:e439-e452. 2018
- A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration‐resistant prostate cancer. Prostate. 78:1053-1062. 2018
- Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy. Clinical Oncology. 30:658-666. 2018
- PET/CT of Dementia. American Journal of Roentgenology. 211:246-259. 2018
- Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer. ACP journal club. 168:459-459. 2018
- Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First Observations.. Clinical Nuclear Medicine. 43:213-216. 2018
- Pulmonary nodules as incidental findings. CANADIAN MEDICAL ASSOCIATION JOURNAL. 190:E167-E167. 2018
- Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. Journal of Nuclear Medicine. 58:2026-2037. 2017
- Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers. PET Clinics. 12:393-405. 2017
- Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer. ACP journal club. 167:341-341. 2017
- Stereotactic ablative radiotherapy (SABR) for oligoprogressive metastatic castration-resistant prostate cancer (mCRPC) during abiraterone therapy: A phase I study. Annals of Oncology. 28:v292-v292. 2017
- Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 58:1264-1269. 2017
- Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline. Clinical Oncology. 29:348-355. 2017
- Prevalence of oligoprogressive, metastatic castration-resistant prostate cancer (mCRPC) amenable to stereotactic ablative radiotherapy (SABR) in men undergoing abiraterone acetate (AA) therapy.. Journal of Clinical Oncology. 35:e16509-e16509. 2017
- Postoperative Adjuvant Systemic Therapy in Completely Resected Non–Small-Cell Lung Cancer: A Systematic Review. Clinical Lung Cancer. 18:259-273.e8. 2017
- Desirable Properties of Radiopharmaceuticals for Sentinel Node Mapping in Patients With Breast Cancer Given the Paradigm Shift in Patient Management. Clinical Nuclear Medicine. 42:275-279. 2017
- Joint reconstruction of Ictal/inter-ictal SPECT data for improved epileptic foci localization. Medical Physics. 44:1437-1444. 2017
- Self-management education interventions for patients with cancer: a systematic review. Supportive Care in Cancer. 25:1323-1355. 2017
- Prevalence of oligoprogressive, metastatic castration-resistant prostate cancer (mCRPC) amenable to stereotactic ablative radiotherapy (SABR) in men undergoing abiraterone acetate (AA) therapy.. Journal of Clinical Oncology. 35:e587-e587. 2017
- A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 23:935-945. 2017
- Molecular Imaging and Precision Medicine in Lung Cancer. PET Clinics. 12:53-62. 2017
- Response Assessment Criteria and Their Applications in Lymphoma: Part 2. Journal of Nuclear Medicine. 58:13-22. 2017
- SNMMI Comment on the 2016 Society of Surgical Oncology “Choosing Wisely” Recommendation on the Use of PET/CT in Colorectal Cancer. Journal of Nuclear Medicine. 58:11-12. 2017
- Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic review. Cancer Treatment Reviews. 51:35-45. 2016
- Evidence-based guideline recommendations on treatment strategies for localized Ewing's sarcoma of bone following neo-adjuvant chemotherapy. Surgical Oncology. 25:92-97. 2016
- Response Assessment Criteria and Their Applications in Lymphoma: Part 1. Journal of Nuclear Medicine. 57:928-935. 2016
- Diagnosing dementia. CANADIAN MEDICAL ASSOCIATION JOURNAL. 188:603-603. 2016
- Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases. Urologic Oncology: Seminars and Original Investigations. 34:225-232. 2016
- Gender Differences in Radiation Dose From Nuclear Cardiology Studies Across the World. JACC Cardiovascular Imaging. 9:376-384. 2016
- Imaging Biomarkers in Immunotherapy. Biomarkers in Cancer. 8s2:BIC.S31805-BIC.S31805. 2016
- Targeted Radionuclide Therapy: Practical Applications and Future Prospects. Biomarkers in Cancer. 8s2:BIC.S31804-BIC.S31804. 2016
- Proceedings of the Second NCI–SNMMI Workshop on Targeted Radionuclide Therapy. Journal of Nuclear Medicine. 56:1119-1129. 2015
- [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments. Translational Oncology. 8:147-153. 2015
- (18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer.. American Journal of Nuclear Medicine and Molecular Imaging. 5:72-82. 2015
- Fluorodeoxyglucose Uptake in Lipomatous Hypertrophy of the Interatrial Septum is Not Likely Related to Brown Adipose Tissue. World Journal of Nuclear Medicine. 14:72-72. 2015
- Beyond current guidelines: reduction in minimum administered radiopharmaceutical activity with preserved diagnostic image quality in pediatric hepatobiliary scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging. 41:2346-2353. 2014
- Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 17:325-331. 2014
- Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma. Cancer Imaging. 14:30. 2014
- 18F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 55:1473-1480. 2014
- Guideline for referral of patients with suspected colorectal cancer by family physicians and other primary care providers.. Canadian Family Physician. 60:717-e390. 2014
- Guideline for referral of patients with suspected lung cancer by family physicians and other primary care providers.. Canadian Family Physician. 60:711-e382. 2014
- Systematic review of clinical features of suspected colorectal cancer in primary care.. Canadian Family Physician. 60:e405-e415. 2014
- Systematic review of guidelines for the management of suspected lung cancer in primary care.. Canadian Family Physician. 60:e395-e404. 2014
- Abdomen. PET Clinics. 9:169-183. 2014
- Results of a phase II trial of abiraterone acetate (AA) combined with dutasteride (DUT) for men with metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32:126-126. 2014
- Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging. Journal of Nuclear Medicine. 55:337-348. 2014
- Imaging in Prostate Carcinoma. Hematology/Oncology Clinics of North America. 27:1163-1187. 2013
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin. Journal of Clinical Oncology. 31:3182-3190. 2013
- Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up. Abdominal Radiology. 38:728-735. 2013
- Exploratory Evaluation of MR Permeability with 18F-FDG PET Mapping in Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 54:1237-1243. 2013
- Update on Imaging of Vulvar Squamous Cell Carcinoma. American Journal of Roentgenology. 201:W147-W157. 2013
- Reporting Guidance for Oncologic 18F-FDG PET/CT Imaging. Journal of Nuclear Medicine. 54:756-761. 2013
- Imaging Features of Primary and Secondary Adult Rhabdomyosarcoma. American Journal of Roentgenology. 199:W694-W703. 2012
- MRI for Evaluation of Myeloid Sarcoma in Adults: A Single-Institution 10-Year Experience. American Journal of Roentgenology. 199:1193-1198. 2012
- Pneumatosis Intestinalis and Bowel Perforation Associated With Molecular Targeted Therapy: An Emerging Problem and the Role of Radiologists in Its Management. American Journal of Roentgenology. 199:1259-1265. 2012
- PET/CT and Renal Pathology: A Blind Spot for Radiologists? Part 1, Primary Pathology. American Journal of Roentgenology. 199:W163-W167. 2012
- PET/CT and Renal Pathology: A Blind Spot for Radiologists? Part 2???Lymphoma, Leukemia, and Metastatic Disease. American Journal of Roentgenology. 199:W168-W174. 2012
- Multimodality imaging in amyloidosis. Cancer Imaging. 12:109-117. 2012
- Esophageal gastrointestinal stromal tumor: report of 7 patients. Cancer Imaging. 12:100-108. 2012
- Pheochromocytoma and paraganglioma: imaging characteristics. Cancer Imaging. 12:153-162. 2012
- Pheochromocytoma and paraganglioma: nimaging characteristics. Cancer Imaging. 12:153-162. 2012
- Reduction in Radiation Dose in Mercaptoacetyltriglycerine Renography with Enhanced Planar Processing. Radiology. 261:907-915. 2011
- FDG Uptake in Lipomatous Hypertrophy of the Interatrial Septum Is Not Likely Related to Brown Adipose Tissue. Clinical Nuclear Medicine. 36:767-769. 2011
- Imaging in Renal Cell Carcinoma. Hematology/Oncology Clinics of North America. 25:687-715. 2011
- Abscopal Effect in a Patient With Metastatic Merkel Cell Carcinoma Following Radiation Therapy: Potential Role of Induced Antitumor Immunity. JAMA dermatology. 147:870-870. 2011
- Imaging of Liposarcoma: Classification, Patterns of Tumor Recurrence, and Response to Treatment. American Journal of Roentgenology. 197:W37-W43. 2011
- Brown adipose tissue 18F-FDG uptake in pediatric PET/CT imaging. Pediatric Radiology. 41:759-768. 2011
- Nuclear Medicine in the First Year of Life. Journal of Nuclear Medicine. 52:905-925. 2011
- End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma. Annals of Oncology. 22:910-915. 2011
- Imaging assessment of pars interarticularis injury in young athletes with back pain: current concepts and imaging methods. ArgoSpine News and Journal. 23:15-18. 2011
- Evaluation of 18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 52:188-195. 2011
- The value of SPECT in the detection of stress injury to the pars interarticularis in patients with low back pain. Journal of Orthopaedic Surgery and Research. 5:13. 2010
- Skeletal Scintigraphy in Pediatric Sports Medicine. American Journal of Roentgenology. 195:1212-1219. 2010
- Seasonal variation in the effect of constant ambient temperature of 24°C in reducing FDG uptake by brown adipose tissue in children. European Journal of Nuclear Medicine and Molecular Imaging. 37:1854-1860. 2010
- Constant ambient temperature of 24°C significantly reduces FDG uptake by brown adipose tissue in children scanned during the winter. European Journal of Nuclear Medicine and Molecular Imaging. 36:602-606. 2009
- Endovascular Repair of Traumatic Mesocaval Fistula. Journal of Vascular and Interventional Radiology. 19:1659-1661. 2008
- Contrast Echocardiography Grading Predicts Pulmonary Arteriovenous Malformations on CT. Chest. 132:18-23. 2007
- Sonography for assessment of haemophilic arthropathy in children: a systematic protocol. Haemophilia. 13:293-304. 2007
- Systemic therapy for advanced uterine sarcoma: A systematic review of the literature. Gynecologic Oncology. 97:624-637. 2005
- Lateral diffusion of the total polar lipids from Thermoplasma acidophilum in multilamellar liposomes. Biochimica et Biophysica Acta: international journal of biochemistry and biophysics. 1369:259-266. 1998
-
preprints